Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,720.56
(
0.32%
)
US TECH 100
24,160.80
(
0.61%
)
Dow Jones
47,038.31
(
0.20%
)
Brent Oil
100.83
(
2.57%
)
Bitcoin
74,632.11
(
-0.28%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: MotionMan post# 83376

Wednesday, 09/09/2009 5:01:29 PM

Wednesday, September 09, 2009 5:01:29 PM

Post# of 257251

MNTA – anything noteworthy said at the Rodman and Renshaw conference?

This was the most consequential excerpt:

“Because there was [bulk heparin] contamination in China, that has been another approval hurdle for us… We’ve had to go through a full set of inspections on our supply chain and I am pleased to say it is now complete and we have no areas of concern on our supply chain, so we really feel at this point in time that the FDA has what they need in hand to approve this product.”

This is the most confidant Wheeler has ever sounded on the outcome of the FDA’s review.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now